Ignite Creation Date:
2024-05-06 @ 8:05 PM
Last Modification Date:
2024-10-26 @ 3:20 PM
Study NCT ID:
NCT06246916
Status:
RECRUITING
Last Update Posted:
2024-05-01
First Post:
2024-01-30
Brief Title:
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma
Sponsor:
Regeneron Pharmaceuticals
Organization:
Regeneron Pharmaceuticals
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-08-19
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-03-22
Primary Completion Date Type:
ESTIMATED
Completion Date:
2033-06-26
Completion Date Type:
ESTIMATED
First Submit Date:
2024-01-30
First Submit QC Date:
January 30 2024
Study First Post Date:
2024-02-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-23
Last Update Post Date:
2024-05-01
Last Update Post Date Type:
ACTUAL